Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

A new compound shows promise as a topical treatment for hair loss.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Minoxidil affects collagen-related genes, potentially helping treat fibrosis.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Enzyme purified and characterized for minoxidil sulphation in rat liver.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Erlotinib can cause hair loss as a side effect.

RIPK1 inhibitors might help prevent alopecia areata.